Standardization is more important than ever with the increasing globalization and commercialization in the life sciences sector.  When a pharmaceutical company develops a new drug in the U.S. that will be manufactured and tested around the world, they need technology to ensure measurements of components down to a billionth of a liter will be comparable from Boston to Frankfurt to Shanghai.    President and Co-Founder Kirby Pilcher describes Artel products and services – which enable just such precision for measuring tiny, nearly invisible quantities of liquid – as an “essential yardstick.”

READ THE FULL ARTICLE (PDF)